MAST Biosurgery

MAST Biosurgery is a privately held, commercial-stage medical device company with a focus on bioresorbable sheets for surgical applications. The company has a portfolio of branded products, including SurgiWrap, OrthoWrap, CardioWrap, and Frost, targeting distinct surgical markets such as general, orthopedic, and cardiothoracic surgery. Its value proposition centers on providing temporary, absorbable scaffolds that support tissue healing while reducing risks like infection, adhesion formation, and chronic inflammation. As a commercial entity, MAST operates in the competitive but growing biosurgery and regenerative medicine market.

Proprietary bioresorbable polymer sheets (porous, non-porous, perforated) designed to provide temporary structural support for tissue healing and then safely absorb, eliminating permanent foreign material.

MAST competes in the biosurgery market against major players like Johnson & Johnson (Ethicon), Baxter, Integra LifeSciences, and Medtronic, which offer a wide range of adhesion barriers and surgical meshes. Its niche is focused specifically on engineered synthetic polymer sheets, competing on product-specific handling and resorption profiles rather than a broad portfolio.